A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

from Feed: All Latest https://ift.tt/ZrfD9Oj
via IFTTT

No comments:

Post a Comment

The First Seven Things to Cut From Your Budget When You Lose Your Job

Losing your job can be overwhelming, but taking immediate control of your finances is crucial for maintaining stability during your job sear...